Wondering where the venture capital funding has gone in the healthcare industry? According to CB Insights, it’s the following 10 cities–for Q3 ’13 at least. (Listed in order of amounts of deals; note that though San Francisco saw more deals, San Diego saw more funding.)
- San Francisco, Calif.: 7 deals, $77 million
- San Diego, Calif.: 6 deals, $168 million
- South San Francisco, Calif.: 5 deals, $50 million
- Lexington, Mass.: 3 deals, $55 million
- Cambridge, Mass.: 3 deals, $38 million
- Durham, N.C.: 2 deals, $45 million
- Watertown, Mass.: 1 deal, $60 million
- Lake Forest, Calif.: 1 deal, $55 million
- Chelsea, Mass.: 1 deal, $38 million
- Orem, Utah: 1 deal, $30 million
The report lists the top five deals overall for the quarter as Dicerna Pharmaceuticals, ReVision Optics, aTyr Pharma, Otonomy and Argos Therapeutics. For more healthcare highlights from the report, click here.
